# Simponi

NDC: 57894-070
Generic name: golimumab
Labeler / Manufacturer: Janssen Biotech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20090425

FDA application: BLA125289

## Active ingredients

- GOLIMUMAB: 50 mg/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"57894-070"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=57894-070
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f86cb4a7-c358-4136-ae57-b32bda9bba00
